It's about restoring or amplifying what should already be happening which is why the side effect profiles of most therapeutic peptides are generally favorable, and why this category of treatment has attracted significant clinical research interest over the past decade
In this context, also for practical purposes, providing that the therapeutic effects speak for themselves, we provide a good background for further application of BPC 157 as a therapy
We were suddenly thrown into a world of IVs, antibiotics, steroids, pain meds, blood draws, and round-the-clock monitoring
A 2017 study by Hsieh and colleagues in Journal of Molecular Medicine reported that BPC-157, in chick chorioallantoic membrane, rat hind-limb ischemia, and HUVEC models, directionally increased vessel density, accelerated blood-flow recovery in ischemic muscle, and time-dependently activated the VEGFR2-Akt-eNOS signaling pathway via VEGFR2 internalization a mechanistic preclinical finding for which numeric effect sizes are not reported in the abstract
Get In Touch